Pancreatic cancer is difficult to treat. While precision has helped make significant strides in improved overall survival in other cancers, pancreatic cancer has been left behind. This week, Astra Zeneca and Merck’s Lynparza, a drug that targets the BRCA mutation, was cleared by the FDA. The BRCA mutation is found in breast and ovarian cancers. A […]